Expression of proteins associated with hypoxia and Wnt pathway activation is of prognostic significance in hepatocellular carcinoma

Virchows Archiv

Volumn 466, Issue 5, 2015, Pages 541-548

  Srivastava, Supriya ^a   Thakkar, Bhavin ^a   Yeoh, Khay Guan ^b   Ho, Khek Yu ^b   Teh, Ming ^b   Soong, Richie ^b   Salto Tellez, Manuel ^b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

CA IX; HIF 1 ; Liver cancer; Prognosis; Survival; Wnt pathway

Indexed keywords

TUMOR MARKER;

AGED; CELL HYPOXIA; DISEASE FREE SURVIVAL; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TISSUE MICROARRAY; WNT SIGNALING PATHWAY;

AGED; CARCINOMA, HEPATOCELLULAR; CELL HYPOXIA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; WNT SIGNALING PATHWAY;

EID: 84937511095     PISSN: 09456317     EISSN: 14322307     Source Type: Journal    
DOI: 10.1007/s00428-015-1745-4     Document Type: Article

References (44)

1. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) (2013) SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014
2. D’Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44:217e31
3. Tsochatzis EA, Bosch J, Burroughs AK (2014) Liver cirrhosis. Lancet 17:1749e61
4. Chen XP, Qiu FZ, Wu ZD, Zhang ZW, Huang ZY, Chen YF (2006) Long term outcome of resection of large hepatocellular carcinoma. Br J Surg 93(5):600–606
5. Vakili K, Pomposelli JJ, Cheah YL et al (2009) Living donor liver transplantation for hepatocellular carcinoma: increased recurrence but improved survival. Liver Transpl 15:1861–1866
6. Sangiovanni A, Prati GM, Fasani P, Ronchi G, Romeo R, Manini M et al (2006) The natural history of compensated cirrhosis due to hepatitis C virus: a 17-year cohort study of 214 patients. Hepatology 43:1303e10
7. Lim HY, Sohn I, Deng S, Lee J, Jung SH, Mao M, Xu J, Wang K, Shi S, Joh JW, Choi YL, Park CK (2013) Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling. Ann Surg Oncol 20(12):3747–3753
8. Pang RW, Poon RT (2007) From molecular biology to targeted therapies for hepatocellular carcinoma: the future is now. Oncology 72:30–44
9. Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM (2007) Genomics and signaling pathways in hepatocellular carcinoma. Semin Liver Dis 27:55–76
10. Gwak GY, Yoon JH, Kim KM, Lee HS, Chung JW, Gores GJ (2005) Hypoxia stimulates proliferation of human hepatoma cells through the induction of hexokinase II expression. J Hepatol 42:358–64
11. Gort EH, Groot AJ, van der Wall E, van Diest PJ, Vooijs MA (2008) Hypoxic regulation of metastasis via hypoxia-inducible factors. Curr Mol Med 8:60–67
12. Barsoum IB, Smallwood CA, Siemens DR, Graham CH (2014) A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells. Cancer Res 74(3):665–6674
13. Lu X, Kang Y (2010) Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin Cancer Res 16(24):5928–5935
14. Xie H, Song J, Liu K et al (2008) The expression of hypoxia-inducible factor-1α in hepatitis B virus-related hepatocellular carcinoma: correlation with patients’ prognosis and hepatitis B virus X protein. Dig Dis Sci 53:3225–3233
15. Pastorekova S, Ratcliffe PJ, Pastorek J (2008) Molecular mechanisms of carbonic anhydrase IX-mediated pH regulation under hypoxia. BJU Int 101:8–15
16. Pastorekova S, Zatovicova M, Pastorek J (2008) Cancer-associated carbonic anhydrases and their inhibition. Curr Pharm Des 14:685–98
17. Swinson DEB, Jones JL, Richardson D et al (2003) Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in Non-small-cell lung cancer. J Clin Oncol 21:473–482
18. Beasley NJ, Wykoff CC, Watson PH et al (2001) Carbonic anhydrase IX, an endogenous hypoxia marker, expression in head and neck squamous cell carcinoma and its relationship to hypoxia, necrosis, and microvessel density. Cancer Res 61:5262–5267
19. Su-jong Y, Yoon J-h, Lee J-h et al (2011) Inhibition of hypoxia-inducible carbonic anhydrase-IX enhances hexokinase II inhibitor-induced hepatocellular carcinoma cell apoptosis. Acta Pharmacol Sin 32:912–920
20. Lim JH, Chun YS, Park JW (2008) Hypoxia-inducible factor-1α obstructs a Wnt signaling pathway by inhibiting the hARD1-mediated activation of β-catenin. Cancer Res 68:5177–5184
21. Edmondson HA, Steiner PE (1954) Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 7:462–503
22. Sobin LH, Wittekind C (eds) (2002) UICC (International Union against Cancer) TNM classification of malignant tumors, 6th ed. Wiley, New York, pp 1–264
23. Llovet JM, Bru C, Bruix J (1999) Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Disv 19:329e38
24. Das K, Mohd Omar MF, Ong CW et al (2008) TRARESA: tissue microarray-based hospital system for biomarker validation and discovery. Pathology 40:441–449
25. Srivastava S, Wong KF, Ong CW et al (2012) A morpho-molecular prognostic model for hepatocellular carcinoma. Br J Cancer 107:334–39
26. Guo C, Liu QG, Yang W, Zhang ZL, Yao YM (2008) Relation among p130Cas, E-cadherin and B-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 7:490–496
27. Saarnio J, Parkkila S, Parkkila AK et al (1998) Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J of Pathol 153:279–285
28. Cho I-R, Koh S-S, Min H-J et al (2010) Down-regulation of HIF-1α by oncolytic reovirus infection independently of VHL and p53. Cancer Gene Ther 17:365–372
29. Zeng G, Apte U, Cieply B, Singh S, Monga SP (2007) siRNA-mediated beta-catenin knockdown in human hepatoma cells results in decreased growth and survival. Neoplasia 9:951–959
30. Li Y, Lu W, King TD et al (2010) Dkk1 stabilizes Wnt co-receptor LRP6: implication for Wnt ligand-induced LRP6 down-regulation. PLoS One 5:e11014
31. Huang SM, Mishina YM, Liu S et al (2009) Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 461:614–620
32. Kaidi A, Williams AC, Paraskeva C (2007) Interaction between β-catenin and HIF-1 promotes cellular adaptation to hypoxia. Nat Cell Biol 9:210–217
33. 2 regulates stem cells through Wnt/β-catenin signalling. Nat Cell Biol 12:1007–1013
34. Lehwald N, Tao G-Z, Jang KY et al (2011) Wnt-β-catenin signaling protects against hepatic ischemia and reperfusion injury in mice. Gastroenterol 141:707–718
35. Liu L, Zhu XD, Wang WQ, Sorkin M, Knoefel WT, Sylvester KG (2010) Activation of β-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis. Clin Cancer Res 16:2740–2750
36. Teicher BA, Liu SD, Liu JT, Holden SA, Herman TS (1993) A carbonic anhydrase inhibitor as a potential modulator of cancer therapies. Anticancer Res 13:1549–1556
37. Parkkila S, Rajaniemi H, Parkkila AK et al (2000) Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. Proc Natl Acad Sci 97:2220–2224
38. Zatovicova M, Jelenska L, Hulikova A et al (2010) Carbonic anhydrase IX as an anticancer therapy target: preclinical evaluation of internalizing monoclonal antibody directed to catalytic domain. Curr Pharm Des 16(29):3255–3263
39. Lou Y, McDonald PC, Oloumi A et al (2011) Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res 71(9):3364–3376
40. 2 tension. Proc Natl Acad Sci 92:5510–5514
41. Wilson GK, Tennant DA, McKeating JA (2014) Hypoxia inducible factors in liver disease and hepatocellular carcinoma: current understanding and future directions. J of Hepatol 61(6):1397–1406
42. Dai C-X, Gao Q, Qiu S-J et al (2009) Hypoxia-inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a critical prognostic factor in patients with HCC after surgery. BMC Cancer 9:418
43. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE (2004) HIF-1α induces cell cycle arrest by functionally counteracting Myc. EMBO J 23:1949–1956
44. Jing SW, Wang YD, Chen LQ et al (2013) Hypoxia suppresses E-cadherin and enhances matrix metalloproteinase-2 expression favoring esophageal carcinoma migration and invasion via hypoxia inducible factor-1 alpha activation. Dis Esophagus 26(1):75–83